Abstract: The disclosure provides methods and systems for verifying exercise data of a user. The method may include acquiring a post containing exercise data about an exercise regimen performed by a user. The method may also include transmitting a request to a verification device for a verification result for the post and receiving from the verification device, a set of data containing a result of the verification process for the post. The method may further include causing the user devices to display the post and/or the verification results. This disclosure provides a centralized platform to showcase and track the progress of the exercise regimen performed by the user and by other users who are followed by the user.

Abstract: A method for the preparation of (CF3)2CHOCH2F (Sevoflurane) is presented, which comprises providing a mixture of (CF3)2CHOCH2Cl, potassium fluoride, water, and a phase transfer catalyst and reacting the mixture to form (CF3)2CHOCH2F.

Abstract: A method for the preparation of (CF3)2CHOCH2F (Sevoflurane) is presented, which comprises providing a mixture of (CF3)2CHOCH2Cl, potassium fluoride, water, and a phase transfer catalyst and reacting the mixture to form (CF3)2CHOCH2F.

Abstract: The invention relates to a method of treating diverse human disorders that may arise, in part, out of sleep hypoxia and oxygen deprivation occurring in the context of sleep apnea/hypopnea disturbances. The disorders that may be treated by the invention comprise gastroesophageal reflux disease (GERD), asthma-associated gastroesophageal reflux (GER), GER-associated asthma, asthma, cardiomyopathy, cardioarrhythmia, congestive heart failure, sudden infant death syndrome, and diverse neurologic conditions. The mode of treatment uses somatostatin receptor ligands (SstRLs), particularly somatostatin-receptor agonists. The invention concerns the method of treatment utilizing, and compositions comprising SstRLs and somatostatin receptor agonists, including agonists of the somatostatin receptor types 2 and 5, particularly, the type 2A receptor (SsR-2A), including octreotide and lanreotide.

Abstract: This invention provides methods for inhibiting the proliferation of brain or hepatic metastases, in vivo, by contacting the cells with lonidamine and radiation.

Abstract: An automatic chemical mixing system using a single level sensor, preferably an ultrasonic sensor, for monitoring the contents of a mixing tank. The level sensor provides an analog signal to a controller indicative of the level of liquid in the tank. Supply pipes from several sources of different chemicals lead to the tank through respective controllable valves. The required percentage of each chemical can be entered manually into the controller and each valve is opened in turn by the controller until the various percentages are reached. Provision is also made for adding small quantities of a further chemical which is supplied by a metering pump. The controller ensures that this is done after the other chemicals have been added. A mixer, also under control of the controller, starts running when all the chemicals have been added and stops when a predetermined low level is reached.